Veterinary Medicines

Eurican Herpes 205 (--) - Powder and solvent for emulsion for injection

Authorised
  • Canine herpesvirus, strain F205, glycoproteins
Download as PDF

Product identification

Medicine name:
Eurican Herpes 205 (--) - Powder and solvent for emulsion for injection
Active substance:
  • Canine herpesvirus, strain F205, glycoproteins
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine herpesvirus, strain F205, glycoproteins
    Presentation_strength:0.3 µg to 1.75 µg Reference:Hse Comments:Antigens (amount expressed in µg of gB glycoproteins) Index:0
Pharmaceutical form:
  • Powder and solvent for emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Bulgaria
  • Czechia
  • France
  • Hungary
  • Poland
  • Slovakia
  • Spain
Package description:
  • Packaging:Powder: bottle (glass); solvent: bottle (glass), Package_size:Powder: 1 bottle; solvent: 1 bottle, Content:Powder: 1 dose; solvent: 1 ml
  • Packaging:Powder: bottle (glass); solvent: bottle (glass), Package_size:Powder: 50 bottles; solvent: 50 bottles, Content:Powder: 1 ml; solvent: 1 ml
  • Packaging:Powder: bottle (glass); solvent: bottle (glass), Package_size:Powder: 10 bottles; solvent 10 bottles, Content:Powder: 1 dose; solvent: 1 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 20/06/2024
Download
Bulgarian (PDF)
Published on: 20/06/2024
Download
Croatian (PDF)
Published on: 20/06/2024
Download
Czech (PDF)
Published on: 20/06/2024
Download
Danish (PDF)
Published on: 20/06/2024
Download
Dutch (PDF)
Published on: 20/06/2024
Download
Estonian (PDF)
Published on: 20/06/2024
Download
Finnish (PDF)
Published on: 20/06/2024
Download
French (PDF)
Published on: 20/06/2024
Download
German (PDF)
Published on: 20/06/2024
Download
Greek (PDF)
Published on: 20/06/2024
Download
Hungarian (PDF)
Published on: 20/06/2024
Download
Icelandic (PDF)
Published on: 20/06/2024
Download
Italian (PDF)
Published on: 20/06/2024
Download
Latvian (PDF)
Published on: 20/06/2024
Download
Lithuanian (PDF)
Published on: 20/06/2024
Download
Maltese (PDF)
Published on: 20/06/2024
Download
Norwegian (PDF)
Published on: 20/06/2024
Download
Polish (PDF)
Published on: 20/06/2024
Download
Portuguese (PDF)
Published on: 20/06/2024
Download
Romanian (PDF)
Published on: 20/06/2024
Download
Slovak (PDF)
Published on: 20/06/2024
Download
Slovenian (PDF)
Published on: 20/06/2024
Download
Spanish (PDF)
Published on: 20/06/2024
Download
Swedish (PDF)
Published on: 20/06/2024
Download

ema-puar-eurican-herpes-205-v-059-par-en.pdf

English (PDF)
Published on: 14/03/2023
Download